Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy

Transplant Infectious Disease(2024)10.1111/tid.14367Source: DataRank Database

A randomized, placebo‐controlled, dose‐escalation phase I/II multicenter trial of low‐dose cidofovir for BK polyomavirus nephropathy is a research paper published in Transplant Infectious Disease (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: hybridTopics (43)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

John W. Gnann,James Rooney ORCID,V. Ram Peddi,Alexander C. Wiseman ORCID,Michelle A. Josephson ORCID

Live enrichment

PubMed:39226143 PMC:PMC11666883

National Institute of Allergy and Infectious Diseases

Grant: AI‐30025

National Institute of Allergy and Infectious Diseases

Grant: AI-30025

National Institutes of Health

Grant: N01AI030025-003

CASG-26630025

hybridLicense: cc-by

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tid.14367

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.14367

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11666883/pdf/TID-26-e14367.pdf

Europe_PMChttps://europepmc.org/articles/PMC11666883

Europe_PMChttps://europepmc.org/articles/PMC11666883?pdf=render

Fields of Study

0303 health sciences03 medical and health sciences

MeSH Terms

HumansBK VirusPolyomavirus InfectionsTumor Virus InfectionsKidney DiseasesCytosineAntiviral AgentsGlomerular Filtration RateTreatment OutcomeKidney TransplantationDouble-Blind MethodDose-Response Relationship, DrugAdultAgedMiddle AgedFemaleMaleOrganophosphonatesCidofovir

Keywords

Randomized controlled trialKidney TransplantCidofovirBk VirusAdultMalePolyomavirus InfectionsDose-Response Relationship, DrugOrganophosphonatesMiddle AgedAntiviral AgentsKidney TransplantationCytosineTumor Virus InfectionsTreatment OutcomeDouble-Blind MethodHumansOriginal ArticleFemaleKidney DiseasesAgedGlomerular Filtration Rate